<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <title>Submission 1089 from Anon (session_user_id: fee39a87659692737f52e5e57e6a56ab9763a74a)</title>
    <link href="../../../export.css" rel="stylesheet">
  </head>
  <body>
    <h1>Submission 1089 from Anon (session_user_id: fee39a87659692737f52e5e57e6a56ab9763a74a)</h1>
    <div class="field-name" id="d6002606a5ec3d03">Q1. Describe how DNA methylation is altered in cancer.
In your answer include the following points:
<br><p></p><ul><li>Describe the normal
function of DNA methylation at CpG islands.<br></li><li>Describe how DNA
methylation of CpG islands is disrupted in cancer.<br></li><li>Explain how disruption of
DNA methylation at CpG islands contributes to cancer.<br></li><li>Describe the normal
function of DNA methylation in intergenic regions and repetitive elements.<br></li><li>Describe how DNA
methylation in intergenic regions and repetitive elements is disrupted in cancer.<br></li><li>Explain how disruption
of DNA methylation in intergenic regions and repetitive elements contributes to
cancer.<br></li></ul><p></p></div>
    <div class="field-value">

<p class="MsoNormal" style="margin-bottom:.0001pt;line-height:normal;"><span lang="en" xml:lang="en">In the genome, there are so-called CpG islands, CG
rich regions in the promoter region of the gene. </span><span title="Normaal gesproken zijn deze gebieden gehypomethyleerd, waardoor het DNA toegankelijk is voor transcriptiefactoren en transcriptie kan plaatsvinden.">Normally,
these areas are hypomethylated, so that the DNA is accessible to transcription
factors, and transcription can take place. </span><span title="In de tumorcel vindt door tussenkomst van DNMT's methyleringvan CpG's in de promotorregio plaats.">In
<span> </span>tumors, through DNMT's these CpG sites are
hypermethylated in the promoter region. </span><span title="Dit zorgt ervoor dat het transcriptiecomplex niet kan binden en daardoor worden bijvoorbeeld tumorsuppressor genen stil gelegd.">This
ensures that the transcription complex can not bind and therefore, for example,
tumor suppressor genes are shut down. </span><span title="In de normale situatie zijn de niet-coderende delen van het DNA, intergenic regions and repetitive elements, gehypermethyleerd, hetgeen bijdraagt aan chromosomale stabiliteit en inactivatie van zogenaamde transposons.">In
the normal situation, the non-coding portions of the DNA, repetitive elements
and intergenic regions, are hypermethylated, which contributes to <span> </span>chromosomal stability and inactivanion of transposons.
</span><span title="Naast hypermethylering van CpG-eilanden10 vindt in tumorcellen algemene hypomethylering plaats.">In
addition to hypermethylation of CpG-eilanden <span> </span>found in tumor cells, a general hypomethylation
occers at the repetitive elements and intergenic regions. </span><span title="Dat wil zeggen dat het niet-coderende deel van het genoom buiten de CpG-eilanden dat van nature gemethyleerd is en dus ontoegankelijk is voor transcriptiefactoren, methylgroepen verliest.">There
are indications that the demethylation o the repetitive elements and intergenic
regions leads to chromosomal instability and reactivation of transposons in
certain tumors, such as colon cancer, seems demethylation even a more important
role to play in the development </span><span title="van genomische schade dan de hypermethylering van CpG-eilanden.">of
genomic damage than the hyper-methylation of CpG islands.</span><span style="font-size:9.5pt;font-family:'Quadraat-Regular';" lang="en-us" xml:lang="en-us"></span></p>

</div>

    <div class="field-name" id="323cdd9789545f83">Q2. Describe how disruption of imprinting can contribute to cancer, using the example of the H19/Igf2 cluster. In your
answer include the following points:
<br>
<p></p>
<ul>
    <li>Describe the methylation pattern of the paternal allele and how this determines
        Igf2 expression status.&nbsp;
        <br>
    </li>
    <li>Describe the methylation pattern of the maternal allele and how this determines
        Igf2 expression status.&nbsp;
        <br>
    </li>
    <li>Describe how imprinting at the H19/Igf2 cluster is disrupted in Wilm’s tumour.&nbsp;
        <br>
    </li>
    <li>Explain how disrupting imprinting at the H19/Igf2 cluster contributes to cancer.
        <br>
    </li>
</ul></div>
    <div class="field-value">

<p class="MsoNormal" style="margin-bottom:.0001pt;line-height:normal;"><span class="hps"><span lang="en" xml:lang="en">Upon</span></span><span lang="en" xml:lang="en"> <span class="hps">loss of</span> <span class="hps">imprinting</span>
<span class="hps">the regulation of</span> <span class="hps">genomic imprinting</span>
<span class="hps">is disrupted by</span> <span class="hps">hyper-or</span> <span class="hps">hypo-</span>methylation. <span class="hps">An</span> <span class="hps">example
of this is</span> <span class="hps">loss of</span> <span class="hps">imprinting</span>
<span class="hps">of the</span> <span class="hps">IGF2/H19-locus</span>. <span class="hps">Expression of</span> <span class="hps">IGF2</span> <span class="hps">normally
takes place</span> <span class="hps">from the</span> <span class="hps">paternal</span>
<span class="hps">chromosome</span>. <span class="hps">On</span> <span class="hps">the
paternal</span> <span class="hps">allele</span>, the <span class="hps">ICR</span> <span class="hps">of</span> <span class="hps">H19</span> is <span class="hps">hypermethylated</span>
<span class="hps">and</span> <span class="hps">the</span> <span class="hps">downstream</span>
<span class="hps">enhancers</span> <span class="hps">take care of the expression</span>
<span class="hps">of</span> <span class="hps">IGF2</span> <span class="hps">located</span>
<span class="hps">upstream</span>. <span class="hps">On the maternal</span> <span class="hps">allele</span> <span class="hps">the</span> <span class="hps">insulator</span>
<span class="hps">protein</span> <span class="hps">CTCFensures</span> <span class="hps">the</span> <span class="hps">non-expression</span> <span class="hps">of</span>
<span class="hps">IGF2</span>, but <span class="hps">H19</span> <span class="hps">is</span>
<span class="hps">well</span> <span class="hps">expressed</span>. <span class="hps">Loss
of</span> <span class="hps">imprinting</span> <span class="hps">of</span> <span class="hps">the</span> <span class="hps">maternal chromosome</span> <span class="hps">provides increased</span> <span class="hps">expression of</span> <span class="hps">IGF2</span>, <span class="hps">whereby</span> <span class="hps">the</span>
<span class="hps">ICR</span> <span class="hps">of the maternal</span> <span class="hps">gene</span> <span class="hps">also</span> <span class="hps">is</span> <span class="hps">hypermethylated</span> <span class="hps">and</span> <span class="hps">hence</span>
<span class="hps">H19</span> <span class="hps">is</span> <span class="hps">silenced</span>
<span class="hps">and</span> <span class="hps">IGF2</span> <span class="hps">is
expressed</span> <span class="hps">in</span> <span class="hps">both alleles</span>,
<span class="hps">thus</span> <span class="hps">overexpression of</span> <span class="hps">IGF2</span>, <span class="hps">which plays an important</span> <span class="hps">role, which</span> <span class="hps">in</span> <span class="hps">the</span>
<span class="hps">development</span> <span class="hps">of</span> <span class="hps">Wilm's</span>
<span class="hps">tumor</span>.</span><span style="font-family:'Times New Roman', serif;" lang="en-us" xml:lang="en-us"></span></p>

</div>

    <div class="field-name" id="961ab4c640df430a">Q3. The Economist article “<a href="http://www.economist.com/node/21552168" target="_blank">Cancer’s epicentre</a>” describes several drugs that affect
    epigenetic processes. Explain how Decitabine may be used to treat cancer,
    with reference to effects on the epigenome. In your answer include the
    following points:
<br>
<p></p>
    <ul>
        <li>Identify the class of epigenetic inhibitors that Decitabine belongs to.&nbsp;
            <br>
        </li>
        <li>Describe the impact of Decitabine on DNA methylation.
            <br>
        </li>
        <li>Describe how Decitabine can have an anti-tumour effect.&nbsp;
            <br>
        </li>
    </ul></div>
    <div class="field-value">

<p class="MsoNormal" style="margin-bottom:.0001pt;"><span lang="en-us" xml:lang="en-us">Decitabine
belongs to the group of </span><span lang="en-us" xml:lang="en-us">DNA methyltransferase inhibitors,
action by generally demethylating DNA. <span> </span></span><span lang="en-ca" xml:lang="en-ca">Decitabine is a nucleoside analog and</span><span lang="en-us" xml:lang="en-us"> get incorporated into the DNA upon
replication, and then, DNA methyltransferase comes along bind it, the DNMT1 bind
irreversibly. This means that the action of these DNA methyltransferase
inhibitors is division dependent. Cancer cells, which are dividing much more
rapidly than most other cells in the body will be more severely affected
because they're replicating more.</span><span lang="en-us" xml:lang="en-us"></span></p>

</div>

    <div class="field-name" id="10aa9d89e69a5f7a">Q4. Dr Stephen Baylin speculates in the Economist article that "epigenetic
drugs altered the tumour cells in some lasting way that made them more
susceptible to standard chemotherapy." How can drugs that alter DNA methylation
have effects that last beyond the period of drug treatment? Discuss whether
there are any periods of development when you would avoid treating patients
with such drugs. In your answer include the following points:
<br>
<p></p>
<ul>
    <li>Describe how altering DNA methylation can have enduring effects on the
        epigenome.
        <br>
    </li>
    <li>Define what is meant by a sensitive period.
        <br>
    </li>
    <li>Identify sensitive periods of development.
        <br>
    </li>
    <li>Explain why treating patients during sensitive periods would be inadvisable.
    <br>
</li>
</ul></div>
    <div class="field-value">The atered DNA methylation is during mitosis copied to daughter cells. <span>Epigenetic therapies can effect changes which stop a cancer growing
without having to kill all its cells</span> says Baylin. Sensitive moments ar the moments of inprinting.<br /><br /><br /><br /></div>
  </body>
</html>